首页> 外文期刊>Archives of Clinical and Experimental Surgery >Ultrasound Guided Fine-Needle Aspiration Cytology (FNAC) of Portal Vein Thrombus: A Novel Diagnostic and Staging Technique for Occult Hepatocellular Carcinoma
【24h】

Ultrasound Guided Fine-Needle Aspiration Cytology (FNAC) of Portal Vein Thrombus: A Novel Diagnostic and Staging Technique for Occult Hepatocellular Carcinoma

机译:超声引导的门静脉血栓细针穿刺细胞学检查(FNAC):隐匿性肝细胞癌的一种新的诊断和分期技术

获取原文
           

摘要

Introduction: The diagnosis of Hepatocellular Carcinoma (HCC) is usually established using noninvasive radiological imaging and tumor markers. The stage at diagnosis is a critical factor in the treatment, course and prognosis of HCC. Patients with Tumor Portal vein thrombus (PVT) are considered to have an advanced disease and are only offered palliative therapy. Therefore, every possible attempt should be made to accurately stage HCC. Fine-needle aspiration cytology (FNAC) of PVT is an effective procedure for diagnosing and staging HCC. We present a case where we used Ultrasound (USG) guided FNAC of a PVT to successfully diagnose and stage HCC in the absence of a well-defined liver mass on imaging. Case report: A 43-year-old Hepatitis B surface antigen positive male presented with a 3-month history of fatigue, jaundice and fever. On examination he had hepatomegaly. His liver function tests were elevated, but his alpha-fetoprotein was normal. USG and Computed Tomography (CT) showed a thrombus in the portal vein but failed to show a well-defined liver lesion. FNAC was taken from the PVT, which was positive for malignancy. He was offered palliative chemotherapy and a steroid for his pyrexia. He is on follow-up. Conclusion: FNAC is a safe, quick, easy and economical technique to diagnose and stage HCC in the presence of portal vein thrombus, especially in patients where the tumor is occult on imaging. It also affords an accurate method to differentiate between malignant and nonmalignant PVT, thereby aiding appropriate therapeutic decision making.
机译:简介:肝细胞癌(HCC)的诊断通常使用无创放射影像学检查和肿瘤标记物进行。诊断阶段是肝癌的治疗,病程和预后的关键因素。患有肿瘤门静脉血栓(PVT)的患者被认为患有晚期疾病,仅接受姑息治疗。因此,应尽一切可能准确地分级HCC。 PVT的细针穿刺细胞学检查(FNAC)是诊断和分期HCC的有效方法。我们提出了一个案例,在影像学上没有明确定义的肝脏肿块的情况下,我们使用了超声(USG)引导的PVT FNAC成功诊断和分期了HCC。病例报告:一名43岁的乙型肝炎表面抗原阳性男性,具有3个月的疲劳,黄疸和发烧史。经检查,他患有肝肿大。他的肝功能检查升高,但他的甲胎蛋白正常。 USG和计算机断层扫描(CT)在门静脉显示血栓,但未显示明确的肝脏病变。 FNAC来自PVT,对恶性肿瘤呈阳性。他因发热而接受姑息化疗和类固醇激素治疗。他正在跟进。结论:FNAC是一种在门静脉血栓存在的情况下诊断和分期HCC的安全,快速,简便且经济的技术,特别是在肿瘤隐匿于影像学的患者中。它还提供了区分恶性和非恶性PVT的准确方法,从而有助于做出适当的治疗决策。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号